Get all your news in one place.
100’s of premium titles.
One app.
Start reading
Benzinga
Benzinga
Business
Benzinga Insights

12 Health Care Stocks Moving In Friday's Intraday Session

 

Gainers

  • Unity Biotechnology (NASDAQ:UBX) stock rose 68.8% to $1.44 during Friday's regular session. Trading volume for Unity Biotechnology's stock is 83.5 million as of 13:30 EST. This is 21114.4% of its average full-day volume over the last 100 days. The company's market cap stands at $99.2 million. The company's, Q2 earnings came out today.
  • Invitae (NYSE:NVTA) shares moved upwards by 34.81% to $6.08. Invitae's stock is trading at a volume of 122.3 million shares as of 13:30 EST. This is 802.7% of its average full-day volume over the last 100 days. The company's market cap stands at $1.4 billion. The company's, Q2 earnings came out 3 days ago.
  • Rani Therapeutics Hldgs (NASDAQ:RANI) shares moved upwards by 34.26% to $11.05. Trading volume for this security as of 13:30 EST is 642.0K, which is 1410.2% of its average full-day volume over the last 100 days. The market value of their outstanding shares is at $270.6 million. As per the press release, Q2 earnings came out 2 days ago.
  • ASLAN Pharma (NASDAQ:ASLN) shares moved upwards by 29.85% to $0.9. As of 13:30 EST, ASLAN Pharma's stock is trading at a volume of 753.7K, which is 293.2% of its average full-day volume over the last 100 days. The market value of their outstanding shares is at $62.4 million. As per the press release, Q2 earnings came out today.
  • Liquidia (NASDAQ:LQDA) stock increased by 29.33% to $7.38. As of 13:30 EST, Liquidia's stock is trading at a volume of 12.1 million, which is 756.6% of its average full-day volume over the last 100 days. The company's market cap stands at $475.1 million. The company's, Q2 earnings came out yesterday.
  • Terns Pharma (NASDAQ:TERN) stock moved upwards by 29.04% to $3.11. Trading volume for this security as of 13:30 EST is 3.5 million, which is 2176.5% of its average full-day volume over the last 100 days. The market value of their outstanding shares is at $78.8 million. As per the press release, Q2 earnings came out 4 days ago.

Losers

  • PLx Pharma (NASDAQ:PLXP) stock declined by 39.4% to $1.57 during Friday's regular session. As of 13:30 EST, this security is trading at a volume of 2.1 million shares, making up 1217.5% of its average full-day volume over the last 100 days. The market value of their outstanding shares is at $43.2 million. The company's, Q2 earnings came out today.
  • IMAC Holdings (NASDAQ:BACK) shares declined by 31.33% to $0.65. Trading volume for this security as of 13:30 EST is 2.8 million, which is 3151.1% of its average full-day volume over the last 100 days. The company's market cap stands at $17.1 million.
  • Aptinyx (NASDAQ:APTX) stock declined by 31.02% to $0.41. The current volume of 3.2 million shares is 989.8% of Aptinyx's average full-day volume over the last 100 days (last updated at 13:30 EST). The market value of their outstanding shares is at $28.0 million.
  • Co-Diagnostics (NASDAQ:CODX) shares fell 30.66% to $4.48. Co-Diagnostics's stock is trading at a volume of 2.9 million shares as of 13:30 EST. This is 544.7% of its average full-day volume over the last 100 days. The company's market cap stands at $151.3 million. The company's, Q2 earnings came out yesterday.
  • Palisade Bio (NASDAQ:PALI) stock declined by 29.08% to $0.24. Palisade Bio's stock is trading at a volume of 6.3 million shares as of 13:30 EST. This is 2635.8% of its average full-day volume over the last 100 days. The company's market cap stands at $5.1 million.
  • Sientra (NASDAQ:SIEN) shares fell 23.78% to $0.93. Sientra's stock is trading at a volume of 2.8 million shares as of 13:30 EST. This is 367.1% of its average full-day volume over the last 100 days. The market value of their outstanding shares is at $58.2 million. As per the press release, Q2 earnings came out yesterday. See Also: www.benzinga.com/money/best-healthcare-stocks/

This article was generated by Benzinga's automated content engine and reviewed by an editor.

Sign up to read this article
Read news from 100’s of titles, curated specifically for you.
Already a member? Sign in here
Related Stories
Top stories on inkl right now
One subscription that gives you access to news from hundreds of sites
Already a member? Sign in here
Our Picks
Fourteen days free
Download the app
One app. One membership.
100+ trusted global sources.